We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » WLF: CMS POLICY THREATENS DRUGMAKERS' INVESTMENTS
WLF: CMS POLICY THREATENS DRUGMAKERS' INVESTMENTS
February 17, 2004
Two pending Medicare coverage decisions and an underlying policy stance taken by the Centers for Medicare & Medicaid Services (CMS) are creating a risk that drugmakers may not be able to sell their products to senior citizens, even after obtaining FDA marketing approval, according to the Washington Legal Foundation (WLF).